ENTITY
SYS6041
SYS6041
PulseAugur coverage of SYS6041 — every cluster mentioning SYS6041 across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-06-15 product_launch Xinnuowei's subsidiary received approval for clinical trials of its folate receptor-targeting drug candidate, SYS6041. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Jinneng Technology Denies Molybdenum Use in Semiconductor Memory Chips Amidst Market Rumors
Jinneng Technology has announced that its molybdenum metal products, such as molybdenum powder and targets, are not directly used in semiconductor memory chips. While molybdenum targets are applied in display screen pro…
-
Xinnuowei subsidiary gets drug trial approval; Weiming Environmental Protection secures loan
Xinnuowei's subsidiary, CStone Biopharma, has received approval from China's National Medical Products Administration to conduct clinical trials for SYS6041, a novel folate receptor-targeting antibody-drug conjugate. Th…